Clinical Edge Journal Scan

TET1 and lncRNA may help predict postoperative recurrence of UF


 

Key clinical point: Long noncoding ribonucleic acid (lncRNA) H19 and 10-11 translocation enzyme 1 ( TET1) messenger RNA expression levels showed high diagnostic and predictive values for determining postoperative recurrence of uterine fibroids (UFs).

Major finding: lncRNA H19 ( P = .010) and TET1 ( P = .014) levels independently predicted UF recurrence. The area under the curve values of lncRNA H19 and TET1 for predicting UF recurrence were 0.814 (sensitivity, 81.13%; specificity, 77.27%) and 0.765 (sensitivity, 69.81%; specificity, 77.27%), respectively.

Study details: This study enrolled 75 patients with UFs who underwent surgical treatment and 60 healthy controls. Patients with UF were followed up for 2 years to evaluate postoperative recurrence of UFs.

Disclosures: No information on funding was available. The authors declared no conflict of interests.

Source: Zhan X et al. Clinics. 2021 Sep 28. doi: 10.6061/clinics/2021/e2671.

Recommended Reading

Distinct clinical characteristics and typical morphology distinguishes HLRCC and sporadic uterine leiomyomas
MDedge ObGyn
TVUS + SE presents a specific and sensitive technique for differential diagnosis of uterine fibroids and adenomyosis
MDedge ObGyn
The influence of uterine fibroids on fertility in women planning to become pregnant
MDedge ObGyn
Clinical Edge Journal Scan Commentary: Uterine Fibroids October 2021
MDedge ObGyn
T2 relaxation time predicts effectiveness of MRgHIFU treatment of uterine fibroids
MDedge ObGyn
Single-port laparoscopy myomectomy feasible for treatment of uterine fibroids
MDedge ObGyn
Aging may impair restoration of endometrial blood flow after laparoscopic myomectomy
MDedge ObGyn
Single-layer sutured laparoscopic myomectomy appears safe for subsequent pregnancies
MDedge ObGyn
Uterine fibroids: Nonresponders to elagolix+add-back therapy may still have a clinically meaningful response
MDedge ObGyn
MRI helpful for predicting uterine fibroids shrinkage after GnRH-agonist treatment
MDedge ObGyn